Position in SYRE
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$2,722,246
+$1,828,652 QoQ
Shares Held
53,970
+97.9% QoQ
Ownership
0.062%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2024
7 quarters on record
Voting authority
Sole 0%
Shared 44%
None 56%
Common Shares in SYRE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026VOYA INVESTMENT MANAGEMENT LLC holds $1,307,060,415 across 174 Biotechnology names. SYRE ranks #49 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
349,912 | $270,356,007 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
527,047 | $235,347,566 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
148,488 | $49,130,223 | |
| 4 | PTGX |
Protagonist Therapeutics, Inc
|
454,383 | $47,891,967 | |
| 5 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
656,129 | $41,139,286 | |
| 6 | BBIO |
BridgeBio Pharma, Inc.
|
538,980 | $40,024,653 | |
| 7 | INSM |
INSMED Inc
|
243,706 | $39,850,804 | |
| 8 | SRRK |
Scholar Rock Holding Corp
|
725,409 | $35,661,105 |
All Filings in SYRE
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,722,246 | 53,970 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $893,594 | 27,277 | Shares | Defined | 2026-02-12 | |
| 2025-06-30 | $203,427 | 13,589 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $166,964 | 10,348 | Shares | Defined | 2025-06-18 | |
| 2024-12-31 | $244,323 | 10,495 | Shares | Defined | 2025-05-02 | |
| 2024-09-30 | $333,832 | 11,351 | Shares | Defined | 2025-02-07 | |
| 2024-06-30 | $272,880 | 11,607 | Shares | Defined | 2025-02-07 | |
| No filing history on record for this holder in this stock. | ||||||